About Qiagen NV
QIAGEN N.V. (QIAGEN) is a holding company. The Company and its subsidiaries are engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Sample to Insight solutions are composed of sample and assay technologies, bioinformatics and automation systems. Its bioinformatics solutions interpret data to provide actionable insights. Its automation platforms tie these together in molecular testing workflows-from Sample to Insight. Its Sample to Insight molecular technologies are applicable across a range of applications and customer classes through over 500 core consumable products, as well as instruments that automate the use of these products for sample preparation, analysis and interpretation. Its bioinformatics solutions include the Ingenuity, CLC bio, OmicSoft and BIOBASE portfolios. The Company, through OmicSoft Corporation (OmicSoft), offers solution across the data management and interpretation.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Research Services
- Sub-Industry: Life Sciences Tools & Services
- Exchange: NASDAQ
- Symbol: QGEN
- CUSIP: N7248210
- Previous Close: $28.74
- 50 Day Moving Average: $28.93
- 200 Day Moving Average: $28.27
- 52-Week Range: $20.71 - $30.09
- Trailing P/E Ratio: 82.35
- Foreward P/E Ratio: 20.38
- P/E Growth: 1.88
- Market Cap: $6.49B
- Outstanding Shares: 225,850,000
- Beta: 1.05
- Net Margins: 5.85%
- Return on Equity: 10.01%
- Return on Assets: 6.24%
Companies Related to Qiagen NV:
- Debt-to-Equity Ratio: 0.41%
- Current Ratio: 3.36%
- Quick Ratio: 2.92%
What is Qiagen NV's stock symbol?
Qiagen NV trades on the NASDAQ under the ticker symbol "QGEN."
Where is Qiagen NV's stock going? Where will Qiagen NV's stock price be in 2017?
12 analysts have issued 1 year price targets for Qiagen NV's stock. Their predictions range from $23.00 to $30.00. On average, they expect Qiagen NV's share price to reach $26.33 in the next year.
When will Qiagen NV announce their earnings?
Qiagen NV is scheduled to release their next quarterly earnings announcement on Tuesday, April, 25th 2017.
Who owns Qiagen NV stock?
Qiagen NV's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Baillie Gifford & Co. (3.36%), DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main (1.45%), State Street Corp (1.01%), Credit Agricole S A (0.97%), Frontier Capital Management Co. LLC (0.76%) and Brown Capital Management LLC (0.44%).
Who sold Qiagen NV stock? Who is selling Qiagen NV stock?
Qiagen NV's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Oxford Asset Management, Marshall Wace LLP, Baillie Gifford & Co., Credit Agricole S A, Commerzbank Aktiengesellschaft FI, Guggenheim Capital LLC and State Board of Administration of Florida Retirement System.
Who bought Qiagen NV stock? Who is buying Qiagen NV stock?
Qiagen NV's stock was acquired by a variety of institutional investors in the last quarter, including DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main, Frontier Capital Management Co. LLC, Renaissance Technologies LLC, Russell Investments Group Ltd., Allianz Asset Management AG, State Street Corp, Brown Capital Management LLC and Dimensional Fund Advisors LP.
How do I buy Qiagen NV stock?
Shares of Qiagen NV can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Qiagen NV stock cost?
One share of Qiagen NV stock can currently be purchased for approximately $28.74.